Rama is an entrepreneur who is passionate about developing solutions to accelerate clinical trials. He is currently the CEO/Founder of an innovative Clinical Trials Management and finance company in NJ, USA and has been a speaker at many leading blockchain conferences in the world. He also is an Adjunct Professor of Finance at Fairleigh Dickenson Univ. NJ, where he ran the first seminar on Blockchains for MBAs in 2019. Prior to being an entrepreneur, he was the CFO for Novartis Pharma Russia (2013-2016), where, as a member of the Russian executive team he participated in setting the strategic and operational direction of the Pharma organization in Russia. He also served for a brief period as an interim CEO in Russia.
Rama’s roles over 27 years at Novartis and Eli Lilly, have included being the Global Development Finance Head for Oncology Business, and, Lead Faculty for Novartis’s R&D Finance College - that trained over 150 associates in R&D Finance. He also served as the CFO for Novartis Canada – where he partnered the executive team to move Canada from the bottom two to the top five countries list in Novartis. He has served as a regional finance head for the Novartis Oncology InterContinental Region (seventy-four countries) at its inception. Furthermore, he served as a Financial Advisor in Lilly’s M&A group at their Corporate Finance and Investment Banking Unit, and, helped to set up Lilly’s operations in Africa and India.
He is a member of the CFA Institute, holds an MBA from INSEAD, Indian Institute of Management Calcutta, a B.Tech. from Indian Institute of Technology, Delhi, is bilingual in English & French, and has worked in seven countries.
Rama Krishna Rao's Session: